Microbiome Therapeutics Market Size, Share & Trends Analysis Report By Target Therapy Area (Gastrointestinal and Infectious Diseases, Skin Disorders, Cancer Indications, Other Indications) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Microbiome Therapeutics Market Size Analysis
    1. Introduction
    2. Microbiome Therapeutics Market Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
      1. Gastrointestinal and Infectious Diseases
      2. Skin Disorders
      3. Cancer Indications
      4. Other Indications
  7. North America Microbiome Therapeutics Market Size Analysis
    1. Introduction
    2. Microbiome Therapeutics Market Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
      1. Gastrointestinal and Infectious Diseases
      2. Skin Disorders
      3. Cancer Indications
      4. Other Indications
    3. U.S.
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    4. Canada
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
  8. Europe Microbiome Therapeutics Market Size Analysis
    1. Introduction
    2. Microbiome Therapeutics Market Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
      1. Gastrointestinal and Infectious Diseases
      2. Skin Disorders
      3. Cancer Indications
      4. Other Indications
    3. U.K.
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    4. Germany
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    5. France
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    6. Spain
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    7. Italy
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    8. Russia
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    9. Nordic
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    10. Benelux
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    11. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
  9. APAC Microbiome Therapeutics Market Size Analysis
    1. Introduction
    2. Microbiome Therapeutics Market Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
      1. Gastrointestinal and Infectious Diseases
      2. Skin Disorders
      3. Cancer Indications
      4. Other Indications
    3. China
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    4. Korea
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    5. Japan
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    6. India
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    7. Australia
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    8. Taiwan
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    9. South East Asia
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    10. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
  10. Middle East and Africa Microbiome Therapeutics Market Size Analysis
    1. Introduction
    2. Microbiome Therapeutics Market Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
      1. Gastrointestinal and Infectious Diseases
      2. Skin Disorders
      3. Cancer Indications
      4. Other Indications
    3. UAE
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    4. Turkey
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    5. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    6. South Africa
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    7. Egypt
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    8. Nigeria
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    9. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
  11. LATAM Microbiome Therapeutics Market Size Analysis
    1. Introduction
    2. Microbiome Therapeutics Market Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
      1. Gastrointestinal and Infectious Diseases
      2. Skin Disorders
      3. Cancer Indications
      4. Other Indications
    3. Brazil
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    4. Mexico
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    5. Argentina
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    6. Chile
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    7. Colombia
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
    8. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Target Therapy Area 2022-2034 (USD MILLION/ Units)
        1. Gastrointestinal and Infectious Diseases
        2. Skin Disorders
        3. Cancer Indications
        4. Other Indications
  12. Competitive Landscape
    1. Microbiome Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. 4D pharma plc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Seres Therapeutics Inc.
    3. Microbiotica
    4. Enterome
    5. Destiny Pharma plc
    6. Taisho Pharmaceutical Holdings
    7. AOBiome Therapeutics Inc.
    8. Finch Therapeutics Group
    9. Inc. Ferring Pharmaceuticals
    10. Rebiotix Inc.
    11. Maat Pharma
    12. Vedanta Biosciences Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

We are featured on: